POTENTIAL TREATMENTS AND VACCINES FOR COVID-19:
TACKLING THE WORLD’S MOST URGENT PROBLEM
Virtual Panel Discussion with Alumni in the Medical Research Field
Join the Princeton Club of Dallas-Fort Worth for a virtual panel discussion on potential treatments and vaccines for COVID-19, featuring two Princeton alumni working in the medical research field. See below for event details and to learn more about our panelists. Follow the link to register. All registered participants will receive a link to the meeting before the event.
Mamta K. Jain, MD, MPH, FIDSA – Princeton Class of 1990
Professor of Internal Medicine, Infectious Diseases at UT Southwestern Medical Center
Minghao Li – Princeton Class of 2015
PhD Candidate in Immunology at UT Southwestern Medical Center
Friday, June 5 | 5-6pm CDT
(Link to Zoom meeting will be sent via email the day of the event.)
Register – Here
Mamta K. Jain, ’90
Mamta K. Jain, MD, MPH, FIDSA received AB in Political Science from Princeton in 1990. She then went to Baylor College of Medicine to complete for medical school and internal medicine training and then UT Southwestern Medical School for infectious diseases training.
She is currently Professor of Internal Medicine, Infectious Diseases at UT Southwestern Medical Center. Dr. Jain has focused her career in Infectious Diseases and conducts clinical trials to evaluate new therapies for HIV, hepatitis C, influenza, and now COVID-19. Dr. Jain research focuses on improving clinical outcomes in those with HIV and viral hepatitis.
During this global pandemic, Dr. Jain has been at the forefront of conducting clinical trials for patients with COVID-19 in order to find effective therapies. Her trials have brought access to novel therapies for over 100 patients at UT Southwestern and Parkland Hospital. Dr. Jain is a Fellow of Infectious Disease Society of America and is a member of Standard Practice and Guideline Committee for IDSA. She is a member of the IDSA Guidelines Committee for Infection Prevention for COVID-19.
Minghao Li, ’15
Minghao Li, Princeton Class of 2015, is a PhD candidate in Immunology at UT Southwestern Medical Center where he is studying how the immune system recognizes different disease conditions to activate the appropriate curative immune response. By understanding the molecular mechanisms that activate and deactivate immune responses, he hopes to lay the groundwork for the future development of novel immunotherapies. He is also interested in viruses, having studied the replication cycle of herpesviruses for his senior thesis in Molecular Biology at Princeton.